EFPIA rejects ‘indiscriminate’ transparency
November 16, 2012Medical Communications, Research and Development, Sales and Marketing EFPIA, Goldacre, transparency, trials
Europe’s pharma trade body has poured tepid water on the idea of open access to clinical trial data, saying that …
Orchid exits Chinese joint venture
November 15, 2012Manufacturing and Production North China pharma corp, Orchid
India’s Orchid Chemicals & Pharmaceuticals has ducked out of a joint venture it set up in China ten years ago …
Jeff Jonas joins Shire’s Leadership Team
November 15, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeff Jonas, Shire
Shire has announced that Jeff Jonas has been appointed president of Shire’s Regenerative Medicine (RM) business and will join the …
UK Board appointments at Universal WorldEvents
November 15, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Universal WorldEvents
Healthcare events firm Universal WorldEvents has appointed Denise Abbott and Nicola Burns to its Board. Abbott (pictured) joined Universal WorldEvents …
Forxiga approved in European Union
November 15, 2012Sales and Marketing AstraZeneca, BMS, Forxiga, diabetes
AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga has been approved in Europe – a major filip for …
Regeneron to invest $70m in NYC manufacturing
November 15, 2012Manufacturing and Production NY, Regeneron, Sanofi, US
Regeneron has confirmed it will invest almost $70 million to expand its manufacturing in New York City in a move …
Hunt: England to be technology ‘leader’
November 15, 2012Medical Communications, Sales and Marketing Jeremy Hunt, NHS, telehealth
Technology is to free 100,000 people next year from what health secretary Jeremy Hunt calls the ‘constant merry-go-round’ of doctors’ …
Lundbeck opens first Asian manufacturing plant
November 14, 2012Manufacturing and Production China, Lundbeck
Lundbeck has officially opened its first manufacturing facility in China and says it plans to launch three new drugs there …
Germany dismisses Seroquel XR
November 14, 2012Sales and Marketing AstraZeneca, FDA, Germany, Seroquel XR
AstraZeneca has received another dent in its international attempts to keep the money-spinning antipsychotic Seroquel going in a new form. …
No specific targets in NHS mandate
November 14, 2012Sales and Marketing CCGs, NHS, commissioning
The government has given the first public directive to the nascent NHS Commissioning Board, which assumes its new responsibilities from …
Eugene Washington appointed to J&J Board of directors
November 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eugene Washington, J&J, JJ
Dr Eugene Washington has been appointed to the Board of directors at Johnson & Johnson. Washington serves as vice chancellor …
AstraZeneca signs genome deal
November 13, 2012Research and Development, Sales and Marketing AstraZeneca, Foundation, SMIP
AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …
EFCG calls for mandatory inspection of API plants
November 13, 2012Manufacturing and Production API, EFCG, EU, FMD
The European Fine Chemicals Group (EFCG) has called for all active pharmaceutical ingredient (API) manufacturing facilities to undergo mandatory inspections. …
Hospira on track to return propofol to market
November 13, 2012Manufacturing and Production Ball, Hospira, Teva
Shortages of the short-acting anaesthetic propofol in the US could be helped by the return to market of a generic …
NHS Commissioning Board appoints Patients and Information directors
November 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Coulthard, NHS, NHS Commissioning Board
The NHS Commissioning Board has made a series of appointments to complete its director-level recruitment to the Patients & Information …
Pharma can help NHS transition, says partnership leader
November 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CCGs, Conference, NHS, PCT
A new ABPI team is now ready to help the pharmaceutical industry forge partnerships with the NHS, even as the …
Patients ‘shut out’ of drug price talks
November 13, 2012Sales and Marketing Cancer, NHS, NICE, VBP, prostate
Patients are being excluded from the negotiations between government and the pharma industry on the introduction of Value-Based Pricing (VBP).That …
Pfizer and GSK end agreements
November 12, 2012Research and Development, Sales and Marketing Auxilium, GSK, Pfizer, Xenoport
Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …
Havas Health launches new Global Agency Group, Havas Lynx
November 12, 2012Medical Communications
Euro RSCG Life 4D and Creative Lynx join to form new Global Brand for the next era in Health and …
Contract research news in brief
November 12, 2012Research and Development Bay Bioanalytical Laboratory, Bioclinica, Charles River, ICON, Pacific BioLabs, Quintiles, Vital River
Acquisitions for Charles River and Pacific BioLabs, a new contract for Bioclinica plus updates from Icon and Quintiles.
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
